Conformational perturbation of SARS-CoV-2 spike protein using N-acetyl cysteine: an exploration of probable mechanism of action to combat COVID-19

被引:1
|
作者
Debnath, Utsab [1 ]
Mitra, Amrita [2 ]
Dewaker, Varun [3 ]
Prabhakar, Yenamandra S. [3 ]
Tadala, Raghu [4 ]
Krishnan, Kiran [4 ]
Wagh, Padmakar [4 ]
Velusamy, Umashankar [4 ]
Baliyan, Aastha [5 ]
Kurpad, Anura V. [6 ]
Bhattacharyya, Parthasarathi [7 ]
Mandal, Amit Kumar [5 ]
机构
[1] Univ Petr & Energy Studies, Sch Hlth Sci & Technol, Dehra Dun, India
[2] St Johns Res Inst, Div Mol Med, Clin Prote Unit, Bangalore, India
[3] CSIR, Cent Drug Res Inst, Med & Proc Chem Div, Lucknow, India
[4] Waters India Pvt Ltd 36A, Bengaluru, India
[5] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Nadia 741246, W Bengal, India
[6] St Johns Med Coll, Dept Physiol, Bangalore, India
[7] Inst Pulmocare & Res, Clin Div, Kolkata, India
关键词
SARS-CoV-2; spike protein; disulfide bonds; N-acetyl cysteine (NAC); angiotensin-converting enzyme 2 (ACE2); mass spectrometry; proteomics; molecular docking; MD simulation; MOLECULAR-DYNAMICS; WEB SERVER; ANALOGS;
D O I
10.1080/07391102.2023.2234031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Spike protein is used to target human ACE2 receptor for viral fusion into the human cell. N-acetyl cysteine can interestingly inhibit this viral fusion process by increasing the probability of structural deformation of this viral spike protein. This process may indirectly reduce the intermolecular binding affinity between two enzymes
引用
收藏
页码:5042 / 5052
页数:11
相关论文
共 50 条
  • [41] Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain
    Hahn, Georg
    Wu, Chloe M.
    Lee, Sanghun
    Lutz, Sharon M.
    Khurana, Surender
    Baden, Lindsey R.
    Haneuse, Sebastien
    Qiao, Dandi
    Hecker, Julian
    DeMeo, Dawn L.
    Tanzi, Rudolph E.
    Choudhary, Manish C.
    Etemad, Behzad
    Mohammadi, Abbas
    Esmaeilzadeh, Elmira
    Cho, Michael H.
    Li, Jonathan Z.
    Randolph, Adrienne G.
    Laird, Nan M.
    Weiss, Scott T.
    Silverman, Edwin K.
    Ribbeck, Katharina
    Lange, Christoph
    GENETIC EPIDEMIOLOGY, 2021, 45 (07) : 685 - 693
  • [42] N-terminal Domain (NTD) of Spike Protein from SARS-CoV-2 May Cause COVID-19 Multiple Tropisms and Serve as a Potential Drug Target
    Wu, Guang
    Yan, Shaomin
    2024 24TH INTERNATIONAL CONFERENCE ON TRANSPARENT OPTICAL NETWORKS, ICTON 2024, 2024,
  • [43] Sesquiterpene coumarins of Asafoetida mask the functional site of pathogenic proteins of SARS-CoV-2 to combat COVID-19 disease
    Ramachandran, Surekha
    ANNALS OF PHYTOMEDICINE-AN INTERNATIONAL JOURNAL, 2024, 13 (01): : 495 - 506
  • [44] COVID-19: docking-based virtual screening and molecular dynamics study to identify potential SARS-CoV-2 spike protein inhibitors from plant-based phenolic compounds
    Moradkhani, Shirin
    Farmani, Abbas
    Saidijam, Massoud
    Taherkhani, Amir
    ACTA VIROLOGICA, 2021, 65 (03) : 288 - 302
  • [45] The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic
    Shah, Priyanka
    Canziani, Gabriela A.
    Carter, Erik P.
    Chaiken, Irwin
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [46] Modelling the association between COVID-19 transmissibility and D614G substitution in SARS-CoV-2 spike protein: using the surveillance data in California as an example
    Zhao, Shi
    Lou, Jingzhi
    Cao, Lirong
    Zheng, Hong
    Chong, Marc K. C.
    Chen, Zigui
    Zee, Benny C. Y.
    Chan, Paul K. S.
    Wang, Maggie H.
    THEORETICAL BIOLOGY AND MEDICAL MODELLING, 2021, 18 (01)
  • [47] Mass spectrometry and proteome analysis to identify SARS-CoV-2 protein from COVID-19 patient swab samples
    Banerjee, Arghya
    Pai, Medha Gayathri J.
    Singh, Avinash
    Nissa, Mehar Un
    Srivastava, Sanjeeva
    STAR PROTOCOLS, 2022, 3 (01):
  • [48] Neuropsychiatric Symptoms of COVID-19 Explained by SARS-CoV-2 Proteins' Mimicry of Human Protein Interactions
    Yapici-Eser, Hale
    Koroglu, Yunus Emre
    Oztop-Cakmak, Ozgur
    Keskin, Ozlem
    Gursoy, Attila
    Gursoy-Ozdemir, Yasemin
    FRONTIERS IN HUMAN NEUROSCIENCE, 2021, 15
  • [49] Impaired VEGF-A-Mediated Neurovascular Crosstalk Induced by SARS-CoV-2 Spike Protein: A Potential Hypothesis Explaining Long COVID-19 Symptoms and COVID-19 Vaccine Side Effects?
    Talotta, Rossella
    MICROORGANISMS, 2022, 10 (12)
  • [50] Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate
    Fernandes, Barbara
    Castro, Rute
    Bhoelan, Farien
    Bemelman, Denzel
    Gomes, Ricardo A.
    Costa, Julia
    Gomes-Alves, Patricia
    Stegmann, Toon
    Amacker, Mario
    Alves, Paula M.
    Fleury, Sylvain
    Roldao, Antonio
    PHARMACEUTICS, 2022, 14 (04)